Sacubitril - Valsartan should be the starting treatment in HFrEF patients - Chairperson conclusion
Topic:
Pharmacotherapy
Speaker:
Professor M. Jessup (Dallas, US)
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Mariell Jessup
American Heart Association, Dallas (United States of America)
28
presentations
0
follower
7 more presentations in this session
Access the full session
First-line therapies in heart failure with reduced ejection fraction (HFrEF) - ACE inhibitors or sacubitril/valsartan?
Speakers:
Professor M. Jessup, Professor G. Filippatos, Professor M. Packer, Professor A. Voors, Professor M. Packer
About the event
